PTJ
MIRM icon

Paul Tudor Jones’s Mirum Pharmaceuticals MIRM Stock Holding History

Paul Tudor Jones’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,205
Closed -$411K – 4037
2025
Q4 		$411K Sell
5,205
-22,449
-81% -$1.61M ﹤0.01% 2830
2025
Q3 		$2.03M Buy
+27,654
New +$1.76M ﹤0.01% 1799
2025
Q1 		– Sell
-23,966
Closed -$991K – 3410
2024
Q4 		$991K Buy
+23,966
New +$999K ﹤0.01% 1731
2023
Q4 		– Sell
-19,104
Closed -$604K – 2681
2023
Q3 		$604K Buy
19,104
+7,167
+60% +$196K 0.01% 1581
2023
Q2 		$309K Buy
+11,937
New +$317K ﹤0.01% 1992
2021
Q1 		– Sell
-25,000
Closed -$437K – 1741
2020
Q4 		$437K Buy
+25,000
New +$491K 0.01% 1001

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Paul Tudor Jones's MIRM Position: Q1 2026 in Review

Paul Tudor Jones sold out of Mirum Pharmaceuticals (MIRM) in Q1 2026, closing a stake of 5,205 shares — an estimated $411K sold.

Paul Tudor Jones first reported a position in MIRM in Q4 2020 and held it in 6 quarters. The position peaked at $2.03M in Q3 2025. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Paul Tudor Jones reported no remaining Mirum Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 5,205 Mirum Pharmaceuticals shares in Q1 2026, an estimated $411K.
  • Paul Tudor Jones first reported a position in Mirum Pharmaceuticals in Q4 2020 and held it in 6 quarters.
  • Paul Tudor Jones's Mirum Pharmaceuticals position peaked at $2.03M in Q3 2025.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.